全球爱滋病毒/爱滋病诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计爱滋病毒/爱滋病诊断市场将从 2025 年的 57.8 亿美元成长到 2034 年的 141.2 亿美元，2026 年至 2034 年的复合年增长率为 10.44%。

由于公众意识的提高、早期检测项目的开展以及全球卫生倡议的推进，全球爱滋病毒/爱滋病诊断市场正稳步扩张。爱滋病毒诊断在控制感染传播方面发挥着至关重要的作用，它能够实现早期诊断和适当治疗。各国政府和国际组织正大力投资于筛检宣传活动和检查室基础设施建设，以提高检测服务的可近性。

成长要素包括检测项目的增加、快速诊断试剂盒的广泛普及以及检测技术的进步。尤其是在发展中地区，就地检验和自测检测套组的引入显着提高了检测的可及性。此外，更精准、更快速的诊断工具的开发正在提高检出率，并支持改进患者管理策略。

未来几年，由于全球持续努力消除爱滋病毒/爱滋病这一公共卫生威胁，市场预计将持续成长。分子诊断技术的进步和数位健康技术的融合将提高效率和监测水准。非洲和亚太地区对检测的需求旺盛，预计市场将实现强劲成长，而已开发地区将专注于发展先进的自动化诊断系统。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球爱滋病毒/爱滋病诊断市场：依产品类型划分

• 市场分析、洞察与预测
• 装置
• 试剂盒和试剂
• 其他的

第五章 全球爱滋病毒/爱滋病诊断市场：依检测类型划分

• 市场分析、洞察与预测
• 核酸检测
• 快速检测（POC​​）
• ELISA
• 其他的

第六章 全球爱滋病毒/爱滋病诊断市场：依最终用户划分

• 市场分析、洞察与预测
• 私人考试机构
• 医院
• 研究机构及其他
• 学术机构

第七章 全球爱滋病毒/爱滋病诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Hologic Inc
  • Alere
  • Bio-Rad Laboratories
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • OraSure Technologies Inc
  • Siemens Healthineers
  • Chembio Diagnostic Systems

The HIV/AIDS Diagnostics Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.78 Billion (2025) growing at a CAGR of 10.44% during 2026-2034.

The Global HIV/AIDS Diagnostics market is expanding steadily due to increased awareness, early detection programs, and global health initiatives. HIV diagnostics play a crucial role in controlling the spread of infection by enabling early diagnosis and timely treatment. Governments and international organizations are investing heavily in screening campaigns and laboratory infrastructure to improve access to testing services.

Major growth drivers include the rising number of testing programs, availability of rapid diagnostic kits, and improvements in laboratory technologies. Point-of-care testing and self-testing kits have significantly increased accessibility, especially in developing regions. In addition, ongoing research for more accurate and faster diagnostic tools is enhancing detection rates and supporting better patient management strategies.

In the coming years, the market is expected to grow with continuous global efforts to eliminate HIV/AIDS as a public health threat. Technological advancements in molecular diagnostics and digital health integration will improve efficiency and monitoring. Africa and Asia-Pacific are expected to witness strong growth due to high testing demand, while developed regions focus on advanced and automated diagnostic systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits And Reagents
• Others

By Test Type

• Nucleic Acid Tests
• Rapid Tests (POC)
• ELISA
• Others

By End-user

• Private Diagnostics Laboratories
• Hospitals
• Research Institutes & Others
• Academic

COMPANIES PROFILED

• Hologic Inc, Alere, BioRad Laboratories, Abbott Laboratories, F HoffmannLa Roche Ltd, OraSure Technologies Inc, Siemens Healthineers, Chembio Diagnostic Systems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Nucleic Acid Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Tests (POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Private Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Institutes & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV/AIDS DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hologic Inc
  • 9.2.2 Alere
  • 9.2.3 Bio-Rad Laboratories
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 OraSure Technologies Inc
  • 9.2.7 Siemens Healthineers
  • 9.2.8 Chembio Diagnostic Systems